Health Technology Assessment and Market Access

Health Technology Assessment (HTA) is a systematic evaluation process that analyses the clinical, economic, and social implications of health interventions. It plays a critical role in healthcare decision-making, guiding stakeholders—including government bodies, healthcare providers, and pharmaceutical companies—on whether to adopt new technologies. By assessing factors such as clinical effectiveness, safety, and cost-effectiveness, HTAs help ensure that patients receive the best possible care while optimising resource allocation.

At Clevidence, our HTA process follows a rigorous, multi-step methodology designed to deliver reliable, evidence-based results. We begin with a comprehensive systematic literature review to gather data on the clinical efficacy and safety of the intervention. This is followed by economic modelling, where we evaluate the cost-effectiveness using techniques like cost-utility analysis and budget impact analysis. Finally, we engage key stakeholders to ensure our findings are aligned with practical, real-world needs. This structured approach guarantees high-quality, actionable insights for our clients.